Inventor · disambiguated record
Lu Wang
Also filed as: WANG LU · WANG LU X
11 granted patents·18 pending applications·362 citations·filing 2007–2022
92Inventor score
Top patents by PatentIndex Score
29 records- 0197US9365579B2Tricyclic compoundsABBVIE INC·Filed 2015·Granted Jun 14, 2016·50 cites·15 claims
- 0296US8962629B2Tricyclic compoundsWISHART NEIL·Filed 2009·Granted Feb 24, 2015·56 cites·53 claims
- 0395US8785639B2Substituted dihydropyrazolo[3,4-D]pyrrolo[2,3-B]pyridines and methods of use thereofWISHART NEIL·Filed 2010·Granted Jul 22, 2014·57 cites·9 claims
- 0495US8008481B2Indazole compoundsERICSSON ANNA M·Filed 2007·Granted Aug 30, 2011·112 cites·8 claims
- 0592US8648069B25-substituted indazoles as kinase inhibitorsAKRITOPOULOU-ZANZE IRINI·Filed 2008·Granted Feb 11, 2014·44 cites·7 claims
- 0690US8754107B2Aminopyrrolidines as chemokine receptor antagonistsGEORGE DAWN M·Filed 2007·Granted Jun 17, 2014·24 cites·17 claims
- 0784US9163007B25-substituted indazoles as kinase inhibitorsABBVIE INC·Filed 2013·Granted Oct 20, 2015·8 cites·6 claims
- 0882US7939544B2Octahydropentalene compounds as chemokine receptor antagonistsABBOTT LAB·Filed 2008·Granted May 10, 2011·5 cites·18 claims
- 0980US8598199B2Octahydropentalene compounds as chemokine receptor antagonistsGEORGE DAWN M·Filed 2011·Granted Dec 3, 2013·5 cites·20 claims
- 1078US10772970B2Glucocorticoid receptor agonist and immunoconjugates thereofABBVIE INC·Filed 2018·Granted Sep 15, 2020·1 cites·6 claims
- 1176US2023082167A1Novel tricyclic compoundsABBVIE INC·Filed 2022·Application pending·0 cites
- 1269US2021179556A1Primary carboxamides as btk inhibitorsABBVIE INC·Filed 2021·Application pending·0 cites
- 1366US2019284135A1Primary carboxamides as btk inhibitorsABBVIE INC·Filed 2019·Application pending·0 cites
- 1465US9567339B2Primary carboxamides as BTK inhibitorsABBVIE INC·Filed 2014·Granted Feb 14, 2017·0 cites·20 claims
- 1565US2021061813A1Novel tricyclic compoundsABBVIE INC·Filed 2019·Application pending·0 cites
- 1661US2018291029A1Novel tricyclic compoundsABBVIE INC·Filed 2017·Application pending·0 cites
- 1759US2013216497A1Novel tricyclic compoundsWISHART NEIL·Filed 2013·Application pending·0 cites
- 1858US2017174624A1Primary carboxamides as btk inhibitorsABBVIE INC·Filed 2017·Application pending·0 cites
- 1957US2016326181A1Novel tricyclic compoundsABBVIE INC·Filed 2016·Application pending·0 cites
- 2056US2021015938A1Glucocorticoid receptor agonist and immunoconjugates thereofABBVIE INC·Filed 2020·Application pending·0 cites
- 2155US2016222020A1Novel tricyclic compoundsABBVIE INC·Filed 2016·Application pending·0 cites
- 2251US2012053345A1Indazole CompoundsERICSON ANNA M·Filed 2011·Application pending·0 cites
- 2351US2014349970A1Novel tricyclic compoundsWISHART NEIL·Filed 2014·Application pending·0 cites
- 2450US2009069288A1Novel therapeutic compoundsBREINLINGER ERIC C·Filed 2008·Application pending·0 cites
- 2544US2014315883A16H-IMIDAZO[1,5-a]PYRROLO[2,3-e]PYRAZINE COMPOUNDSBREINLINGER ERIC·Filed 2014·Application pending·0 cites
- 2641US2013072470A1Novel tricyclic compoundsWISHART NEIL·Filed 2012·Application pending·0 cites
- 2741US2022265842A1Anti-cd40 antibody drug conjugatesABBVIE INC·Filed 2018·Application pending·0 cites
- 2840US2012330012A1Novel Tricyclic CompoundsFRANK KRISTINE E·Filed 2012·Application pending·0 cites
- 2937US2011152243A1Novel thienopyrrole compoundsABBOTT LAB·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →